Intravenous alpha-MSH reduces fever in the squirrel monkey.
alpha-MSH reduces fever in rabbits when administered IV, ICV, or by gavage; however, the applicability of this finding to higher species, specifically to primates, has not been determined. In this study, we chose the squirrel monkey as an appropriate primate model since it responds reliably to peripheral administration of bacterial endotoxins that cause fever in man. From pilot studies, doses of S. typhosa endotoxin necessary to produce maximum fever and doses of alpha-MSH which did not cause hypothermia were determined for each animal. In the main experiments endotoxin was given via an indwelling catheter in the saphenous vein, followed by alpha-MSH injections when the rectal temperature increased 0.3 degrees C. alpha-MSH (100-400 micrograms) reduced the area under the fever curve an average of 50.0%, but had no effect on afebrile temperature. Molar equivalent amounts of the antipyretic drug acetaminophen had little effect on fever. These findings support the idea, based on research on rabbits, that alpha-MSH has a role in central modulation of fever.
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal; D004731:Endotoxins; D005334:Fever / Q000188:drug therapy; D007275:Injections, Intravenous; D008297:Male; D009074:Melanocyte-Stimulating Hormones / Q000008:administration & dosage / Q000627:therapeutic use*; D012453:Saimiri; D013997:Time Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004731:Endotoxins; D009074:Melanocyte-Stimulating Hormones